Trial intelligence / Profile preview

GTS-21 for Smoking Cessation and Neurocognition

NCT02432066Phase 2Withdrawn

Sponsor
University of Florida
Start
Sep 2018
Primary completion
Dec 2018
Modality
Small Molecules
01

Overview

A Phase 2 trial of dmxb-a in Tobacco Use Disorder (TUD), sponsored by University of Florida. Planned start Sep 2018; status: withdrawn.

02

Drugs

dmxb-a
03

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT02432066.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02432066.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call